@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_head { this: np:hasAssertion dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_assertion; np:hasProvenance dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_provenance; np:hasPublicationInfo dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_publicationInfo; a np:Nanopublication . dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_assertion a np:Assertion . dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_provenance a np:Provenance . dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_publicationInfo a np:PublicationInfo . } dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_assertion { miriam-gene:7965 a ncit:C16612 . lld:C0023418 a ncit:C7057 . dgn-gda:DGN0c74260106add7824778493bb84636ac sio:SIO_000628 miriam-gene:7965, lld:C0023418; a sio:SIO_001121 . } dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_provenance { dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_assertion dcterms:description "[Our results indicated that (1) the expression of TEL-FGFR3 but not DeltaHLH-TEL-FGFR3 resulted in efficient focus formation in NIH/3T3 cells and conferred interleukin 3 independence to Ba/F3 cells by a constitutive tyrosine kinase activity probably through oligomerization by the HLH domain of TEL; (2) although effector proteins including classical mitogen-activated protein kinase (MAPK), p38 MAPK, phosphatidylinositol 3-kinase (PI3-K), mammalian target or rapamycin (mTOR), signal transducer and activator of transcription 3 (STAT-3) and STAT-5 were activated in TEL-FGFR3 transformants, the growth of the transformants was inhibited by SU5402 (concentration that inhibits 50% [IC5)]=5 microM) and the PI3-K inhibitor, LY294002 (IC5)=10 microM) and wortmannin (IC50=5 microM), but not by U0126, SB203580, or rapamycin; and (3) injection of TEL-FGFR3 transformants induced lethal leukemia into syngeneic mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:15514005; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP466488.RApBCcS-BzE_HBD-gXWl91-x8b_uGYXHVRt5xRivB4QNU130_publicationInfo { this: dcterms:created "2016-05-13T12:45:16+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }